Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient.
We report an instance of critical ovarian hyperstimulation syndrome in a highly responsive in-vitro fertilization patient despite the preventive measure of a 4 day 'coast' interval during which no gonadotrophins were administered while gonadotrophin-releasing hormone agonist therapy continued until serum oestradiol concentrations fell below 3000 pg/ml.
Tortoriello
D V
DV
Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103, USA.
McGovern
P G
PG
Colon
J M
JM
Loughlin
J
J
Santoro
N
N
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D016471:Ovarian Hyperstimulation Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D004958:Estradiol; D005640:Follicle Stimulating Hormone; D016729:Leuprolide